How should I assess for premenstrual dysphoric disorder (PMDD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

PMDD Assessment

Assess for PMDD by having the patient complete prospective daily symptom tracking for at least two consecutive menstrual cycles using a validated tool, as this is the gold-standard diagnostic requirement. 1, 2, 3

Core Diagnostic Approach

The diagnosis of PMDD cannot be made from a single office visit or retrospective recall alone. You must:

  • Require prospective daily ratings across at least 2 full menstrual cycles before confirming diagnosis 1, 2
  • Use validated instruments such as the Daily Record of Severity of Problems (DRSP) or Premenstrual Symptoms Screening Tool (PSST) 4, 5
  • Document that symptoms occur specifically during the luteal phase and resolve within days after menses onset 5, 3

Specific Symptom Criteria to Assess

When evaluating the prospective symptom charts, look for:

Affective symptoms (must have ≥1):

  • Marked mood swings or increased sensitivity to rejection
  • Irritability, anger, or increased interpersonal conflicts
  • Depressed mood, feelings of hopelessness
  • Anxiety or feeling on edge

Additional symptoms (total of ≥5 symptoms including affective):

  • Decreased interest in usual activities
  • Difficulty concentrating
  • Fatigue or lack of energy
  • Changes in appetite or food cravings
  • Sleep disturbances (insomnia or hypersomnia)
  • Feeling overwhelmed or out of control
  • Physical symptoms: breast tenderness, joint/muscle pain, bloating, weight gain 5, 3

Critical Timing Pattern

The symptoms must demonstrate a clear luteal-phase pattern:

  • Symptoms present in the week before menses
  • Symptoms begin to remit within a few days after menstrual onset
  • Symptoms are minimal or absent in the follicular phase (week after menses) 1, 5

Validated Screening Tools

Use the PSST for initial screening - it provides both dimensional severity ratings and can identify patients needing immediate treatment. ROC analysis confirms it effectively recognizes moderate/severe PMS and PMDD when compared to diagnostic interviews 4.

Alternatively, use the DRSP or PRISM calendars, which are specifically designed for prospective daily tracking 5.

Essential Clinical History Elements

Beyond symptom tracking, obtain:

  • Functional impairment assessment: Document specific interference with work, school, social activities, or relationships 1, 5
  • Suicidality screening: PMDD carries elevated suicide risk, particularly during symptomatic phases 1
  • Psychiatric history: Screen for mood disorders, anxiety disorders, and history of trauma, as these may indicate premenstrual exacerbation (PME) rather than pure PMDD 1
  • Contraceptive and pregnancy plans: This affects treatment selection 5
  • Current medications: Antidepressants, antipsychotics, and hormonal contraceptives can alter presentation 6
  • Substance use: May be used for self-medication of symptoms 7

Physical Examination Considerations

While PMDD is primarily a psychiatric diagnosis, perform targeted examination to exclude:

  • Thyroid dysfunction (check for thyromegaly, signs of hypo/hyperthyroidism)
  • Signs of androgen excess (hirsutism, acne) suggesting PCOS
  • Galactorrhea suggesting hyperprolactinemia 6

Differential Diagnosis to Rule Out

Key distinction: PMDD vs PME (Premenstrual Exacerbation)

  • PME affects 50-60% of individuals with existing mood disorders and represents worsening of baseline symptoms premenstrually
  • PMDD shows symptom-free intervals during the follicular phase
  • This distinction is critical as it changes treatment approach 1

Also consider:

  • Major depressive disorder or persistent depressive disorder (symptoms present throughout cycle)
  • Generalized anxiety disorder (no cyclical pattern)
  • Bipolar disorder (mood episodes not tied to menstrual cycle)
  • Thyroid disorders
  • Perimenopause (irregular cycles, different symptom pattern) 3

Common Pitfalls to Avoid

  • Do not diagnose based on retrospective recall alone - studies show poor correlation between retrospective reports and prospective ratings 2
  • Do not accept single-cycle tracking - symptom patterns must be confirmed across at least 2 cycles 1, 3
  • Do not overlook PME - if patient has baseline psychiatric symptoms that worsen premenstrually, this is PME, not PMDD 1
  • Do not miss suicidality assessment - this is a high-risk population requiring specific safety planning 1

Algorithmic Decision Tree

  1. Initial visit: Provide prospective daily rating form (DRSP or PSST)
  2. After 2 cycles: Review completed forms
    • If ≥5 symptoms (including ≥1 affective) present luteal phase only → PMDD diagnosis
    • If symptoms present throughout cycle → Consider other mood disorder
    • If baseline symptoms worsen premenstrually → PME diagnosis
  3. Confirm functional impairment in work, relationships, or daily activities
  4. Assess suicide risk and create safety plan if needed
  5. Proceed to treatment planning based on confirmed diagnosis 1, 5

The prospective tracking requirement is non-negotiable for accurate diagnosis, as approximately 50% of women who retrospectively report premenstrual symptoms do not meet criteria when assessed prospectively 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.